Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lidocaine 200mg/20ml (1%) solution for injection vials
1502010J0AAADAD
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 560 |
|
Anbesol Adult Strength gel
1203010Q0BJAAAI
|
Anbesol (Gel) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 466 |
|
Lidocaine 400mg/20ml (2%) solution for injection ampoules
1502010J0AACUCU
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 427 |
|
Lidocaine hydrochlor 0.5%/Cetylpyr chlor 0.025% gel SF
1502010J0AAEQEQ
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 374 |
|
Zinc oxide 6.6% / Lidocaine 0.7% cream
0107010N0AAAJAJ
|
Lidocaine hydrochloride (Rectal) | Lidocaine hydrochloride | Gastro-Intestinal System | 358 |
|
Lidocaine 400mg/20ml (2%) solution for injection vials
1502010J0AAAHAH
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 329 |
|
Lidocaine 0.05% / Chlorhexidine 0.2% oromucosal spy SF
1203030M0AAAQAQ
|
Lidocaine hydrochloride (Antiseptic Lozenges/Spray) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 291 |
|
Zinc oxide 6.6% / Lidocaine 0.7% ointment
0107010N0AAAHAH
|
Lidocaine hydrochloride (Rectal) | Lidocaine hydrochloride | Gastro-Intestinal System | 273 |
|
Lidocaine 36mg/Adrenaline (base) 22.5microg/1.8ml inj cart
1502010J0AAENEN
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 272 |
|
Lidocaine 2% gel
1502010J0AAEPEP
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 232 |
|
Anbesol teething gel
1203010Q0BJABAJ
|
Anbesol (Gel) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 224 |
|
Lidocaine 200mg/10ml (2%) solution for injection ampoules
1502010J0AACECE
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 207 |
|
Lidocaine 50mg/10ml (0.5%) solution for injection ampoules
1502010J0AACFCF
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 207 |
|
Lidocaine 50mg/5ml (1%) inj Mini-Plasco ampoules (Hameln)
1502010J0BNAKBD
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 193 |
|
Lidocaine 0.33%/Cetylpyridinium chlor 0.1% oromucosal gel SF
1203010Q0AAACAC
|
Lidocaine hydrochloride (Mouthwash) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 158 |
|
Lidocaine 100mg/10ml (1%) inj Mini-Plasco ampoules (B.Braun)
1502010J0BNAFBW
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 146 |
|
Anodesyn ointment
0107010N0BEAAAE
|
Anodesyn | Lidocaine hydrochloride | Gastro-Intestinal System | 145 |
|
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories
0107010N0AAAGAG
|
Lidocaine hydrochloride (Rectal) | Lidocaine hydrochloride | Gastro-Intestinal System | 145 |
|
Xylocaine 2% with Adrenaline 1 in 80,000 Dental inj 2.2ml
1502010J0BBBKCQ
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | 142 |
|
Rexocaine 2% injection 2.2ml cartridges
1502010J0BQAACQ
|
Rexocaine | Lidocaine hydrochloride | Anaesthesia | 121 |
|
Denela 5% cream
1502010J0BUAABY
|
Denela | Lidocaine hydrochloride | Anaesthesia | 118 |
|
Calgel teething gel
1203010Q0BDAAAC
|
Calgel | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 113 |
|
Dentinox teething gel
1203010Q0BEAAAC
|
Dentinox (Mouthwash) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 108 |
|
Lidocaine 100mg/5ml (2%) inj Mini-Plasco ampoules (Hameln)
1502010J0BNAICB
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 97 |
|
Iglu oromucosal gel
1203010Q0BMAAAQ
|
Iglu | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 96 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.